The Ohio State University Comprehensive Cancer Center – Arthur G. James Cancer Hospital and Richard J. Solove Research Institute ·
Area of research
Oncology · Immunology
Research interest
Research interests include Immune Cell Function and Interaction, Immune cells in cancer, Cancer Immunotherapy and Biomarkers, and Cytokine Signaling Pathways and Interactions.
Dual IL-6 and CTLA-4 blockade regresses pancreatic tumors in a T cell– and CXCR3-dependent manner
Single-cell RNA sequencing identifies a population of human liver-type ILC1s
Microenvironmental control of hematopoietic stem cell fate via CXCL8 and protein kinase C
Neoadjuvant PD-1 blockade in patients with resectable desmoplastic melanoma (SWOG 1512).
NCCN Guidelines Insights: Uveal Melanoma, Version 1.2019.
Impact of age‐related T‐cell dynamics on the identification of biomarkers predictive of immunotherapy discontinuation: A prospective cohort study
Cutaneous Melanoma, Version 2.2019, NCCN Clinical Practice Guidelines in Oncology
Soy isoflavones and their metabolites modulate cytokine-induced natural killer cell function
Skin Cancer Screening: Recommendations for Data-Driven Screening Guidelines and a review of the US Preventive Services Task Force Controversy
Immunotherapy of head and neck cancer: Emerging clinical trials from a National Cancer Institute Head and Neck Cancer Steering Committee Planning Meeting